▶︎ CYTOVALE
San Francisco, US · Founded 2013 · Delaware corporation · 10 known investors
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
▶︎ CYTOVALE was founded in 2013 by Ajay Shah, Henry Tse, and Dino DiCarlo.
AS
Ajay ShahinCo-founder & CEO
HT
Henry TseinCo-founder & Chief Technology Officer
DD
Dino DiCarloCo-founder
Board
LF
JF
Investors · 10
Alumni VenturesManchester · $100K – $10M
Basecamp FundManchester · $100K – $10M
Blackhorn VenturesDenver · $500K
Breakout Labs
Breakout VenturesSan Francisco · $500K – $6M
EMV CapitalLondon
IT-Farm CorporationTokyovia Julien Nguyen · inferred
Norwest Venture PartnersMenlo Park · $10M – $30M
Pathway BioventuresChicago
Dolby Family VenturesreportedSan Francisco
Reported raises · per SEC filings
Form D private placements$31.1M disclosed across 3 rounds · 2017–2020
▶$16.4MraisedJan 2022 · 23 investors · BiotechnologyRule 506(b)
▶$16.4MraisedJan 2022 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dino DiCarloDirector, Promoter
- William BlackledgeExecutive Officer
- Lindy FishburneDirector
- Jack FuchsDirector, Promoter
- Ajay ShahExecutive Officer, Director, Promoter
- Henry TseExecutive Officer
- Jordanna Polis SchutzDirector
- Offering amount
- $20M
- Amount sold
- $16.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedOct 2019 · 15 investors · BiotechnologyRule 506(b)
▶$7.4MraisedOct 2019 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lindy FishburneDirector
- Jack FuchsDirector, Promoter
- Dino DiCarloDirector, Promoter
- Ajay ShahExecutive Officer, Director, Promoter
- Jordanna Polis SchutzDirector
- Offering amount
- $8.4M
- Amount sold
- $7.4M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedDec 2017 · 7 investors · OtherRule 506(b)
▶$7.2MraisedDec 2017 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Lindy FishburneDirector
- Ajay ShahExecutive Officer, Director, Promoter
- Dino DiCarloDirector, Promoter
- Jack FuchsDirector, Promoter
- Offering amount
- $11M
- Amount sold
- $7.2M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through ▶︎ CYTOVALE went on to found or lead other companies.
Competitors · 3
by search overlapMedscape519 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Osmosis295 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Labcorp264 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
Companies competing with ▶︎ CYTOVALE for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ▶︎ CYTOVALE do?
- Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings. The company serves healthcare systems and clinicians with diagnostic instruments and solutions.
- Who founded ▶︎ CYTOVALE?
- ▶︎ CYTOVALE was founded by Ajay Shah, Henry Tse, Dino DiCarlo in 2013.
- Who are ▶︎ CYTOVALE's investors?
- ▶︎ CYTOVALE's investors include Alumni Ventures, Basecamp Fund, Blackhorn Ventures, Breakout Labs, Breakout Ventures, EMV Capital, IT-Farm Corporation, Norwest Venture Partners and 2 more.
- How much funding has ▶︎ CYTOVALE raised?
- ▶︎ CYTOVALE has disclosed $31.1M raised across 3 rounds.
- Where is ▶︎ CYTOVALE headquartered?
- ▶︎ CYTOVALE is headquartered in San Francisco, US.